PRGO · Perrigo Company plc
United States · RS rating 90 · As of 2026-10-14
| Price | 15.95 USD |
|---|---|
| 1-day change | +3.8% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 96 / 95 / 25 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 38 / 40 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | +71.9% |
| Sales growth Q/Q | +6.3% |
| Distance from 52-week high | +27.3% |
| Market cap (USD) | $1.6B |